• S N Avdeev, I V Leshchenko, Z R Aisanov, V V Arkhipov, A S Belevskiy, S I Ovcharenko, A V Emelyanov, A I Sinopalnikov, E I Shmelev, and A G Chuchalin.
• Sechenov First Moscow State Medical University (Sechenov University).
• Terapevt Arkh. 2024 Apr 16; 96 (3): 292297292-297.

AbstractChronic obstructive pulmonary disease is now one of the most common noncommunicable diseases and the main causes of morbidity, disability and mortality in the world. In recent years, new approaches to epidemiology, diagnosis, classification (categorization), evaluation of phenotypes, as well as characterization and assessment of the severity of сhronic obstructive pulmonary disease exacerbations have emerged. Modern approaches to starting and subsequent drug therapy have changed significantly. This is largely due to the results of recently conducted major clinical trials, demonstrated high efficacy of triple fixed combinations, including inhaled glucocorticosteroids, long-acting beta-agonists and long-acting anticholinergic drugs. The use of non-medication methods (smoking cessation, physical activity and respiratory rehabilitation) and modern approaches to the treatment of respiratory failure and antibiotic therapy remain important. In terms of their significance, all these updates have a significant impact on real clinical practice and can be considered as a novel paradigm of the approaches to the diagnosis and management of this disease.

17 keywords...

hide…